|
1
|
Henderson BE, Ross R and Bernstein L:
Estrogens as a cause of human cancer: the Richard and Hinda
Rosenthal Foundation award lecture. Cancer Res. 48:246–253.
1988.
|
|
2
|
Feigelson HS, Ross RK, Yu MC, Coetzee GA,
Reichardt JK and Henderson BE: Genetic susceptibility to cancer
from exogenous and endogenous exposures. J Cell Biochem Suppl.
25:15–22. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krieger N: Exposure, susceptibility, and
breast cancer risk: a hypothesis regarding exogenous carcinogens,
breast tissue development, and social gradients, including
black\white differences, in breast cancer incidence. Breast Cancer
Res Treat. 13:205–223. 1989.PubMed/NCBI
|
|
4
|
Dickson RB and Lippman ME: Estrogenic
regulation of growth and polypeptide growth factor secretion in
human breast carcinoma. Endocr Rev. 8:29–43. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duprey P and Paulin D: What can be learned
from intermediate filament gene regulation in the mouse embryo.
Intl J Dev Biol. 39:443–457. 1995.
|
|
6
|
Stewart M: Intermediate filament structure
and assembly. Curr Opin Cell Biol. 5:3–11. 1993. View Article : Google Scholar
|
|
7
|
Gilles C, Polette M, Zahm JM, Tournier JM,
Volders L, Foidart JM and Birembaut P: Vimentin contributes to
human mammary epithelial cell migration. J Cell Sci. 112:4615–4625.
1999.PubMed/NCBI
|
|
8
|
Whipple RA, Balzer EM, Cho EH, Matrone MA,
Yoon JR and Martin SS: Vimentin filaments support extension of
tubulin-based microtentacles in detached breast tumor cells. Cancer
Res. 68:5678–5688. 2008. View Article : Google Scholar
|
|
9
|
Hendrix MJ, Seftor EA, Seftor RE and
Trevor KT: Experimental co-expression of vimentin and keratin
intermediate filaments in human breast cancer cells results in
phenotypic interconversion and increased invasive behavior. Am J
Pathol. 150:483–495. 1997.
|
|
10
|
Swiatek PJ, Lindsell CE, del Amo FF,
Weinmaster G and Gridley T: Notch1 is essential for
postimplantation development in mice. Genes Dev. 8:707–719. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weinmaster G, Roberts VJ and Lemke G:
Notch2: a second mammalian Notch gene. Development. 116:931–941.
1992.PubMed/NCBI
|
|
12
|
Kopan R and Weintraub H: Mouse notch:
expression in hair follicles correlates with cell fate
determination. J Cell Biol. 121:631–641. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uyttendaele H, Marazzi G, Wu G, Yan Q,
Sassoon D and Kitajewski J: Notch4/int-3, a mammary proto-oncogene,
is an endothelial cell-specific mammalian Notch gene. Development.
122:2251–2259. 1996.PubMed/NCBI
|
|
14
|
Girard L, Hanna Z, Beaulieu N, Hoemann CD,
Simard C, Kozak CA and Jolicoeur P: Frequent provirus insertional
mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice
suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes
Dev. 10:1930–1944. 1996. View Article : Google Scholar
|
|
15
|
Balint K, Xiao M, Pinnix CC, Soma A, Veres
I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M and Liu ZJ:
Activation of Notch1 signaling is required for b-catenin-mediated
human primary melanoma progression. J Clin Invest. 115:3166–3176.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoek K, Rimm DL, Williams KR, Zhao H,
Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, et
al: Expression profiling reveals novel pathways in the
transformation of melanocytes to melanomas. Cancer Res.
64:5270–5282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu ZJ, Xiao M, Balint K, Smalley KS,
Brafford P, Qiu R, Pinnix CC, Li X and Herlyn M: Notch1 signaling
promotes primary melanoma progression by activating
mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt
pathways and up-regulating N-cadherin expression. Cancer Res.
66:4182–4190. 2006. View Article : Google Scholar
|
|
18
|
Marino S: Medulloblastoma: developmental
mechanisms out of control. Trends Mol Med. 11:17–22. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hallahan AR, Pritchard JI, Hansen S, et
al: The SmoA1 mouse model reveals that Notch signaling is critical
for the growth and survival of sonic hedgehog-induced
medulloblastomas. Cancer Res. 64:7794–7800. 2004. View Article : Google Scholar
|
|
20
|
Park JT, Li M, Nakayama K, Mao TL,
Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM and Wang TL:
Notch3 gene amplification in ovarian cancer. Cancer Res.
66:6312–6318. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soule HD, Maloney TM, Wolman SR, Peterson
WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks
SC: Isolation and characterization of a spontaneously immortalized
human breast epithelial cell line, MCF-10. Cancer Res.
50:6075–6086. 1990.PubMed/NCBI
|
|
22
|
Calaf GM and Hei TK: Establishment of a
radiation- and estrogen-induced breast cancer model.
Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calaf G and Hei TK: Oncoprotein
expressions in human breast epithelial cells transformed by
high-LET radiation. Int J Radiat Biol. 77:31–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calaf G and Russo J: Transformation of
human breast epithelial cells by chemical carcinogens.
Carcinogenesis. 14:483–492. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Califano A: SPLASH: structural pattern
localization analysis by sequential histograms. Bioinformatics.
16:341–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zajchowski DA, Bartholdi MF, Gong Y,
Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP and
Johnson PH: Identification of gene expression profiles that predict
the aggressive behavior of breast cancer. Cancer Res. 61:5168–5178.
2001.
|
|
27
|
Sommers CL, Walker-Jones D, Heckford SE,
Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach
S and Gelmann EP: Vimentin rather than keratin expression in some
hormone-independent breast cancer cell lines and in
oncogene-transformed mammary epithelial cells. Cancer Res.
49:4258–4263. 1989.
|
|
28
|
Domagala W, Lasota J, Bartkowiak J, Weber
K and Osborn M: Vimentin is preferentially expressed in human
breast carcinomas with low estrogen receptor and high Ki-67 growth
fraction. Am J Pathol. 136:219–227. 1990.
|
|
29
|
Domagala W, Wozniak L, Lasota J, Weber K
and Osborn M: Vimentin is preferentially expressed in high-grade
ductal and medullary, but not in lobular breast carcinomas. Am J
Pathol. 137:1059–1064. 1990.PubMed/NCBI
|
|
30
|
Sørlie T, Perou CM, Tibshirani R, et al:
Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications. Proc Natl Acad Sci USA.
98:10869–10874. 2001.PubMed/NCBI
|
|
31
|
Gilles C, Polette M, Piette J, Delvigne
AC, Thompson EW, Foidart JM and Birembaut P: Vimentin expression in
cervical carcinomas: association with invasive and migratory
potential. J Pathol. 180:175–180. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Heatley MK, Ewings P, Odling Smee W,
Maxwell P and Toner PG: Vimentin expression does not assist in
predicting survival in ductal carcinoma of the breast. Pathology.
34:230–232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumano K, Chiba S, Kunisato A, et al:
Notch1 but not Notch2 is essential for generating hematopoietic
stem cells from endothelial cells. Immunity. 18:699–711. 2003.
View Article : Google Scholar
|
|
34
|
Duncan AW, Rattis FM, DiMascio LN, et al:
Integration of Notch and Wnt signaling in hematopoietic stem cell
maintenance. Nat Immunol. 6:314–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guentchev M and McKay RD: Notch controls
proliferation and differentiation of stem cells in a dose-dependent
manner. Eur J Neurosci. 23:2289–2296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stylianou S, Clarke RB and Brennan K:
Aberrant activation of notch signaling in human breast cancer.
Cancer Res. 66:1517–1525. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Frasor J, Danes JM, Komm B, Chang KC,
Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and
down-regulated gene expression in human breast cancer cells:
insights into gene networks and pathways underlying estrogenic
control of proliferation and cell phenotype. Endocrinology.
144:4562–4574. 2003. View Article : Google Scholar : PubMed/NCBI
|
